Resultados da busca - Cameron J. Turtle
- Mostrando 1 - 20 resultados de 66
- Ir para a próxima página
-
1
-
2
-
3
-
4
Artificial Antigen-Presenting Cells for Use in Adoptive Immunotherapy por Cameron J. Turtle, Stanley R. Riddell
Publicado em 2010Revisão -
5
-
6
Toxicities of CD19 CAR‐T cell immunotherapy por Alexandre V. Hirayama, Cameron J. Turtle
Publicado em 2019Revisão -
7
Neurotoxicity Associated with CD19-Targeted CAR-T Cell Therapies por Juliane Gust, Agne Taraseviciute, Cameron J. Turtle
Publicado em 2018Revisão -
8
Engineered T cells for anti-cancer therapy por Cameron J. Turtle, Michael Hudecek, Michael C. Jensen, Stanley R. Riddell
Publicado em 2012Revisão -
9
-
10
Cytokines in CAR T Cell–Associated Neurotoxicity por Juliane Gust, Rafael Ponce, W. Conrad Liles, Gwenn A. Garden, Cameron J. Turtle
Publicado em 2020Revisão -
11
-
12
Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells por Seitaro Terakura, Tori N. Yamamoto, Rebecca Gardner, Cameron J. Turtle, Michael C. Jensen, Stanley R. Riddell
Publicado em 2011Artigo -
13
Late Effects of CD19-Targeted CAR-T Cell Therapy por Ana Cordeiro, Evandro D. Bezerra, Joshua A. Hill, Cameron J. Turtle, David G. Maloney, Merav Bar
Publicado em 2018Artigo -
14
Engineering Human Peripheral Blood Stem Cell Grafts that Are Depleted of Naïve T Cells and Retain Functional Pathogen-Specific Memory T Cells por Marie Bleakley, Shelly Heimfeld, Lori Jones, Cameron J. Turtle, Diane S. Krause, Stanley R. Riddell, Warren D. Shlomchik
Publicado em 2014Artigo -
15
Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit por Jonathan A. Gutman, Cameron J. Turtle, Thomas Manley, Shelly Heimfeld, Irwin D. Bernstein, Stanley R. Riddell, Colleen Delaney
Publicado em 2009Artigo -
16
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo por Daniel Sommermeyer, Michael Hudecek, Paula L. Kosasih, Tea Gogishvili, David G. Maloney, Cameron J. Turtle, Stanley R. Riddell
Publicado em 2015Artigo -
17
-
18
Factors affecting lymphocyte collection efficiency for the manufacture of chimeric antigen receptor T cells in adults with B‐cell malignancies por Sherilyn A. Tuazon, Ang Li, Theodore A. Gooley, Thomas Eunson, David G. Maloney, Cameron J. Turtle, Michael Linenberger, Laura Connelly‐Smith
Publicado em 2019Artigo -
19
Adoptive Therapy With Chimeric Antigen Receptor–Modified T Cells of Defined Subset Composition por Stanley R. Riddell, Daniel Sommermeyer, Carolina Berger, Lingfeng Liu, Ashwini Balakrishnan, Alexander I. Salter, Michael Hudecek, David G. Maloney, Cameron J. Turtle
Publicado em 2014Revisão -
20
Ferramentas de busca:
Assuntos relacionados
Immunology
Medicine
Immune system
Internal medicine
Chimeric antigen receptor
Biology
T cell
Immunotherapy
Antigen
CD19
Cancer research
Cytokine release syndrome
Genetics
Oncology
Cancer
Biochemistry
CD8
Lymphoma
In vitro
Chemotherapy
Cytotoxic T cell
Antibody
Cell therapy
Stem cell
Toxicity
Virology
Cell biology
Cell
Clinical trial
Cytokine